NCT05761171 2025-12-22A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaChildren's Oncology GroupPhase 2 Active not recruiting78 enrolled
NCT05320380 2023-09-01A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatChildren's Oncology GroupPhase 1/2 Withdrawn